Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Q4 2025 Earnings Call Transcript February 24, 2026 Kiniksa Pharmaceuticals, Ltd.
Moby Strategic Performance and Market Evolution. ARCALYST revenue growth of 62% for full-year 2025 was primarily driv ...
Feb 25 (Reuters) - British luxury car maker Aston Martin will cut its workforce by up to 20%, it said on Wednesday, as it ...
Bank of America 2026 Global Agriculture and Materials Conference February 25, 2026 9:45 AM ESTCompany ParticipantsStephan Tanda ...
Good morning, and welcome to Ionis' Fourth Quarter and Full Year 2025 Financial Results Conference Call. As a reminder, this call is being recorded. At this time, I would like to turn the call over to ...
An independent informational overview of MEDVi's compounded tirzepatide telehealth program, including regulatory ...
Indian drugmaker Dr Reddy's Laboratories is likely to launch its generic semaglutide injection in the country in March under ...
Discover the top 3 undervalued Pharmaceuticals stocks for Wednesday, February 25 based on AAII’s Stock Grades.
Fintech Yendo is looking to triple application volume for its vehicle-secured credit card in 2026 after securing $200 million in recent ...
The "Electronic Drug Delivery System Market - Global Forecast 2026-2032" report has been added to ResearchAndMarkets.com's ...
AI is rapidly making inroads in professional services. A vendor that provides AI for accountants has achieved unicorn status ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results